1. Molecular evaluation of chronic restrain stress in mice model of non metastatic fibrosarcoma
   Gordana Smieško et al, 2020, Journal of Molecular Histology CrossRef
2. Correlation of p16 and nm23-H1 expression levels with incidence and prognosis of soft tissue sarcoma
   Jinpeng Jia et al, 2019, Oncology Letters CrossRef
3. Generation and preclinical characterization of an antibody specific for SEMA4D
   Terrence L. Fisher et al, 2016, mAbs CrossRef
4. Intact CD100–CD72 Interaction Necessary for TCR-Induced T Cell Proliferation
   Xiaojun Jiang et al, 2017, Frontiers in Immunology CrossRef
5. Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents
   Iratxe Zuazo-Gaztelu et al, 2019, Cancer Research CrossRef
6. Association between prognosis and SEMA4D/Plexin-B1 expression in various malignancies
   Yibo Yang et al, 2019, Medicine CrossRef
7. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
   Elizabeth E. Evans et al, 2015, Cancer Immunology Research CrossRef
8. The role of the semaphorins in cancer
   Gera Neufeld et al, 2016, Cell Adhesion & Migration CrossRef
9. Regulation of Angiogenesis and Tumor Progression by Semaphorins
   Gera Neufeld et al, 2015, Semaphorins CrossRef
10. Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis
    Kamilla Westarp Zornhagen et al, 2015, PLOS ONE CrossRef
11. Saturation monitoring of VX15/2503, a novel semaphorin 4D‐specific antibody, in clinical trials
    Terrence L. Fisher et al, 2016, Cytometry Part B: Clinical Cytometry CrossRef
12. Sema4D correlates with tumour immune infiltration and is a prognostic biomarker in bladder cancer, renal clear cell carcinoma, melanoma and thymoma
    Qiongyu Lu et al, 2021, Autoimmunity CrossRef
13. Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors
    Amita Patnaik et al, 2016, Clinical Cancer Research CrossRef
14. Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer
    Jie Yi et al, 2017, Oncotarget CrossRef
15. Histopathological Comparison Of Biopsy And Resection Materials In Bone And Soft Tissue Tumors: The Experience of a Tertiary Oncology Referral Center “Istanbul Medeniyet University Prof.Dr. Süleyman Yalçın City Hospital”
    Ayşe Nur TOKSÖZ YILDIRIM et al, 2021, Konuralp Tıp Dergisi CrossRef
16. Raf Kinase Inhibitor Protein Expression and Prognostic Value in Soft Tissue Sarcomas
    Olga Martinho et al, 2016, Pathobiology CrossRef
17. TERT Promoter Mutations in Soft Tissue Sarcomas
    Nathália C. Campanella et al, 2016, The International Journal of Biological Markers CrossRef
18. Semaphorin 4D as a guidance molecule in the immune system
    Elena Kuklina, 2021, International Reviews of Immunology CrossRef
19. Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases
    Lik Hang Lee et al, 2014, Scientific Reports CrossRef